ATB200-03: A PHASE 3 DOUBLE-BLIND RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OFINTRAVENOUS ATB200 CO-ADMINISTERED WITH ORAL AT2221 IN ADULT SUBJECTS WITH LATE ONSETPOMPE DISEASE COMPARED WITH ALGLUCOSIDASE ALFA/PLACEBO

Project: Research project

Project Details

Description

ATB200-03: A PHASE 3 DOUBLE-BLIND RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF INTRAVENOUS ATB200 CO-ADMINISTERED WITH ORAL AT2221 IN ADULT SUBJECTS WITH LATE ONSET POMPE DISEASE COMPARED WITH ALGLUCOSIDASE ALFA/PLACEBO
StatusActive
Effective start/end date8/1/1912/31/20

Funding

  • Amicus Therapeutics

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.